Primary hepatocellular carcinoma--etiology, pathogenesis, and prevention

Area of Science:

• Hepatology
• Virology
• Oncology

Background:

• Primary hepatocellular carcinoma (PHC) is a common cancer, particularly in men.
• PHC is often associated with underlying liver conditions like cirrhosis or chronic hepatitis.
• Persistent infection with hepatitis B virus (HBV) is implicated in the majority of PHC cases.

Purpose of the Study:

• To present evidence linking persistent hepatitis B virus (HBV) infection to primary hepatocellular carcinoma (PHC).
• To propose a model for HBV's role in PHC pathogenesis.
• To explore the potential of HBV vaccination in preventing PHC.

Main Methods:

• Review of evidence associating persistent HBV infection with PHC.
• Development of a pathogenetic model for HBV in PHC.
• Evaluation of HBV vaccine efficacy in preventing acute HBV infection.

Main Results:

• The majority of PHC cases are associated with, and likely caused by, persistent HBV infection.
• A model is proposed detailing HBV's role in PHC development.
• An HBV vaccine has demonstrated safety and efficacy in preventing acute HBV infection in adult men.

Conclusions:

• Preventing persistent HBV infections could prevent most PHC cases.
• Widespread HBV vaccination in endemic areas may lead to a reduction in chronic liver disease.
• If HBV vaccination prevents chronic liver disease, it is likely to prevent PHC.